Exscientia's rising cash burn and stagnant operating revenue are worrisome. Shareholders could face costly dilution if shares are sold to fund another year's operations. However, Exscientia's cash runway is seen as relatively promising.
$微軟(MSFT.US)$$C3.ai(AI.US)$$谷歌-C(GOOG.US)$$Exscientia(EXAI.US)$$Relay Therapeutics(RLAY.US)$ Oppenheimer strategist John Stoltzfus has outlined 10 predictions for the transformative impact of generative AI across various industries. The key focus of generative AI lies in its revolutionary potential to create entirely novel designs and products that may surpass human imagination. 1. Healthcare Augm...
Exscientia股票討論區
Looking forward to year 2024
Generative AI could upend every sector. Oppenheimer has 10 predictions for how it plays out
Oppenheimer strategist John Stoltzfus has outlined 10 predictions for the transformative impact of generative AI across various industries. The key focus of generative AI lies in its revolutionary potential to create entirely novel designs and products that may surpass human imagination.
1. Healthcare Augm...
Outlooks are very strong
Exscientia Looks Promising In AI-Driven Drug Development (NASDAQ:EXAI)" data-render="ssr
暫無評論